Cargando…
USL255 extended-release topiramate: Dose-proportional pharmacokinetics and tolerability in healthy volunteers
OBJECTIVE: Evaluate the pharmacokinetics (PK), safety, and tolerability of single doses of once-daily USL255, Qudexy XR (topiramate) extended-release capsules, over a wide dosing range. METHODS: Two single-dose, phase I studies in healthy adults were used to evaluate the PK profile and maximum toler...
Autores principales: | Clark, Annie M, Halvorsen, Mark B, Braun, Tricia L, Johnson, Krista M, Cloyd, James C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283972/ https://www.ncbi.nlm.nih.gov/pubmed/24861853 http://dx.doi.org/10.1111/epi.12654 |
Ejemplares similares
-
Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study
por: Chung, Steve S, et al.
Publicado: (2014) -
Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy
por: Vuu, Irene, et al.
Publicado: (2016) -
USLE-Based Assessment of Soil Erosion by Water in the Nyabarongo River Catchment, Rwanda
por: Karamage, Fidele, et al.
Publicado: (2016) -
Locally measured USLE K factor expands sustainable agricultural land in Palau
por: Oda, Masato, et al.
Publicado: (2022) -
The Arabidopsis USL1 controls multiple aspects of development by affecting late endosome morphology
por: Yuan, Rongrong, et al.
Publicado: (2018)